Pfizer Stops Enrollment In COVID-Pill Trial After Latest Lousy Results
Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid – its COVID-19 antiviral pill – for standard-risk COVID-19 patients after the latest results suggested the…